Tolevamer
- Generic Name
- Tolevamer
- Brand Names
- Kayexalate, Kionex, Resonium Calcium, Solystat
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 28210-41-5
- Unique Ingredient Identifier
- ZSL2FB6GXN
- Background
Sodium polystyrene sulfonate is a medication used to treat abnormally high potassium levels. It may be taken orally or by rectum, as an enema, and functions as a potassium-binding resin in the intestines. It is also an effective topical microbicide and spermicide, inhibiting the genital transfection of, among others, HIV.
- Indication
Used to treat abnormally high potassium levels.
- Associated Conditions
- Hyperkalemia
- Associated Therapies
- -
SZC Versus SPS for Treatment of Hyperkalemia in Hemodialysis Patients
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-09-08
- Last Posted Date
- 2024-08-13
- Lead Sponsor
- Alexandria University
- Target Recruit Count
- 80
- Registration Number
- NCT06029179
- Locations
- 🇪🇬
Faculty of Medicine, Aexandria University, Alexandria, Egypt
Efficacy of Sodium Polystyrene Sulfonate in the Treatment of Hyperkaliemia in Pre-dialysis Patients
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-02-17
- Last Posted Date
- 2014-10-03
- Lead Sponsor
- Maisonneuve-Rosemont Hospital
- Target Recruit Count
- 38
- Registration Number
- NCT02065076
- Locations
- 🇨🇦
Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada
Safety and Efficacy of Sodium Polystyrene Sulfonate in Hyperkalemia
Phase 4
Terminated
- Conditions
- Interventions
- First Posted Date
- 2013-05-31
- Last Posted Date
- 2014-09-03
- Lead Sponsor
- ZS Pharma, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT01866709
- Locations
- 🇺🇸
Riverside Clinical Research, Edgewater, Florida, United States
Phase II Study of the Pathophysiology and Treatment With Enalapril and Polystyrene Sulfonate for Pseudohypoaldosteronism, Type I
Phase 2
Completed
- Conditions
- First Posted Date
- 1999-10-19
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Center for Research Resources (NCRR)
- Target Recruit Count
- 1
- Registration Number
- NCT00004328
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath